Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.471EUR
−34.01 MEUR
57.62 M
About Aldeyra Therapeutics, Inc.
Sector
Industry
CEO
Todd C. Brady
Website
Headquarters
Lexington
Employees (FY)
10
Founded
2004
FIGI
BBG011FHV622
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ALDEYRA THERAPEUT.DL-,001 stocks are traded under the ticker 137.
ALDEYRA THERAPEUT.DL-,001 is going to release the next earnings report on Aug 2, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track ALDEYRA THERAPEUT.DL-,001 financials in yearly and quarterly reports right on TradingView.
137 net income for the last quarter is −7.49 M EUR, while the quarter before that showed −4.31 M EUR of net income which accounts for −73.94% change. Track more ALDEYRA THERAPEUT.DL-,001 financial stats to get the full picture.
No, 137 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 137 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALDEYRA THERAPEUT.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
As of May 10, 2024, the company has 10.00 employees. See our rating of the largest employees — is ALDEYRA THERAPEUT.DL-,001 on this list?
We've gathered analysts' opinions on ALDEYRA THERAPEUT.DL-,001 future price: according to them, 137 price has a max estimate of 10.16 EUR and a min estimate of 6.46 EUR. Watch 137 chart and read a more detailed ALDEYRA THERAPEUT.DL-,001 stock forecast: see what analysts think of ALDEYRA THERAPEUT.DL-,001 and suggest that you do with its stocks.